Studies on the Plasmodium vivax relapse pattern in Delhi, India.
about
Determinants of relapse periodicity in Plasmodium vivax malariaThe potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW IndiaTriangular test applied to the clinical trial of azithromycin against relapses in Plasmodium vivax infectionsAllelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinentPlasmodium vivax polymorphism in a clinical drug trialEpidemiology of Plasmodium vivax Malaria in IndiaModeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivoElimination of Plasmodium falciparum malaria in Tajikistan.Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivaxGenotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infectionPrevalence and clinical manifestations of malaria in Aligarh, India.Genetic diversity of Plasmodium vivax in Kolkata, IndiaNeglected Plasmodium vivax malaria in northeastern States of India.Molecular Monitoring of Plasmodium vivax Infection after Radical Treatment in Southeastern IranSimple Molecular Methods for Early Detection of Chloroquine Drug Resistance in Plasmodium vivax and Plasmodium falciparumEffectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia.Natural relapses in vivax malaria induced by Anopheles mosquitoes.Battling malaria iceberg incorporating strategic reforms in achieving Millennium Development Goals & malaria elimination in India.RADICAL CURE OF VIVAX MALARIA : 5 OR 14 DAYSAnopheline species and their Plasmodium infection status in Aligarh, IndiaManagement of relapsing Plasmodium vivax malariaA study on relapse/re-infection rate of Plasmodium vivax malaria and identification of the predominant genotypes of P. vivax in two endemic districts of NepalDetermination of the Plasmodium vivax relapse pattern in Camopi, French Guiana.Mass primaquine treatment to eliminate vivax malaria: lessons from the past.Therapeutic Assessment of Primaquine for Radical Cure of Plasmodium vivax Malaria at Primary and Tertiary Care Centres in Southwestern India.Malaria Epidemiology at the Clone Level.Molecular characterization and phylogenetic analysis of Plasmodium vivax, Plasmodium falciparum, Plasmodium ovale, Plasmodium malariae and Plasmodium cynomolgi.Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria.A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India
P2860
Q17485692-73B2E76F-1E61-46E1-A94D-DEAEDE5DECE8Q21562247-FB1576E8-DC74-4EE3-9F1B-256BA7EFE6DDQ24799242-20A0F132-3ADD-4FB3-8E65-02C7FB21A415Q27497226-17D3C71F-A0B8-45EF-A90B-FC0316391DDAQ28347253-BB9A4292-7F56-4AD4-B7C4-700F30DB0141Q28355353-3C5F2A20-AF5D-4408-9626-54777A0536CFQ28544459-AF591D92-4254-4790-B9FD-D0BF41AD830CQ30854065-9FFB0189-752C-4FE3-98DF-82270E1447B1Q33612286-F9343995-AE85-4714-BC80-A066863C142EQ34252526-5853C5C6-A209-4C17-9733-894F778E0F5FQ34341592-A71EFD6E-9C38-4E0C-8695-FAB91F48CC69Q34490613-FFEB843C-C378-45B9-8E42-0183AD512FCFQ34775169-1B63468E-48A1-46F6-84C7-D75BF18CB6BDQ35017420-F60B0654-7443-45AE-99EA-D9AB4BDD66BDQ35877848-DA2D7DCF-A496-4AA7-851E-B7C19B801239Q36064945-8E0A8277-BE47-49D6-B5BE-8F2143444D50Q36133602-2F21B66B-7694-46BA-A93F-88B3A45D5212Q36235143-8C1E21A7-4121-4D27-A613-2D2A21AC654CQ36361232-827186A7-C2DE-4660-BD3B-78DA35DE7E84Q36642605-D7E0602B-0A9C-4F09-8AA9-05B59A57FA97Q36728673-B64AE36B-DE96-4E34-8809-7FBE9599A04EQ37048123-C1E24314-ABB5-4E54-80C6-2C88FA308A98Q37191738-E36B5B86-5B1F-43FC-BD72-0F216A145E4FQ37290599-2E2E0FDA-1F79-4FE4-9030-7CD4A45D4D15Q37359621-849DDFE3-FAB0-4509-A5A8-09825D812E78Q37475221-95BEAA1F-D09F-442F-B92B-2CD891D800EEQ37597901-5B8DCA99-DF85-4DB5-90B0-4052FB47C791Q37606572-45A5CDE7-E4D1-4578-B4D7-A7CE7B3D78C4Q46014409-2B2585A8-C71D-425C-AACE-6645E511FA70Q46401986-24DFE20B-34C7-4452-81F0-2AB140F24075Q51816573-FD739E26-A819-4FF0-A4AF-0732CF73C165Q58768459-780E07EB-E630-487B-A3B9-490E4475C640
P2860
Studies on the Plasmodium vivax relapse pattern in Delhi, India.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Studies on the Plasmodium vivax relapse pattern in Delhi, India.
@en
type
label
Studies on the Plasmodium vivax relapse pattern in Delhi, India.
@en
prefLabel
Studies on the Plasmodium vivax relapse pattern in Delhi, India.
@en
P1476
Studies on the Plasmodium vivax relapse pattern in Delhi, India.
@en
P304
P407
P577
1998-07-01T00:00:00Z